SBFI Inhibitors Reprogram Transcriptomic Landscape of Prostate Cancer Cells Leading to Cell Death
Our findings demonstrate that SBFI-1143 significantly alters the transcriptomic landscape of prostate cancer and may serve as a potentially effective therapeutic option for this disease.
Authors
- Agnieszka B. Bialkowska (ORCID: https://orcid.org/0000-0003-2127-7714)
- Iwao Ojima (ORCID: https://orcid.org/0000-0002-3628-1161)
- Martin Kaczocha (ORCID: https://orcid.org/0000-0002-2527-1398)
- Chris Gordon (ORCID: https://orcid.org/0000-0002-2784-5201)
- Sadhana Rajput (ORCID: https://orcid.org/0000-0001-9406-3157)
- Hehe Wang (ORCID: https://orcid.org/0000-0002-1735-3481)
- Joseph F. LaComb (ORCID: https://orcid.org/0000-0002-2981-1072)
- Manisha Sarder
Institutions
- Stony Brook School (US)
- Stony Brook University (US)
Publication Details
- Journal
- Cancers
- Published
- 2025-11-21
- DOI
- https://doi.org/10.3390/cancers17233723
- Primary Topic
- Blood Coagulation and Thrombosis Mechanisms
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Institutes of Health